1. AstraZeneca and Amgen get optimistic phase 3 asthma drug results — Pfizer/BioNTech begin studies for third booster dose and development of vaccine for variants — Merck KGaA in biobucks pact with Debiopharm for next-gen cancer asset See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Jobs & Business Opportunities - Northern Cal/SF


Sort By:
Title ↓
Replies Views
Last Message
  1. pharmalaw
    Replies:
    0
    Views:
    1,743

Thread Display Options

Loading...